Sign In
Buy NTLA
$13.02
-0.110 (-0.84%)
At Close: Jun 03, 2026
6 Stock Charts to Watch: BILI, CSIQ, EGO, GLPI, NNDM, PAAS
12:00am, Wednesday, 20'th May 2020
Stocks Analysis by Harry Boxer covering: SPDR S&P 500, Ceragon Networks Ltd, Canadian Solar Inc, Dynavax Technologies Corporation. Read Harry Boxer's latest article on Investing.com
Intellia Therapeutics Sees Relative Strength Rating Rise To 92 Amid Cancer Treatment Development
11:12pm, Monday, 18'th May 2020
Intellia Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
The 3 Best Biotech Stocks to Own in 2020
02:37pm, Thursday, 14'th May 2020
By 2024, the biotech sector could rocket to $775 billion with plenty of long-term growth catalysts. And that's great news for biotech stocks.
Detection in one hour, as sensitive as PCR test: Debojyoti Chakraborty
06:51pm, Tuesday, 12'th May 2020
Senior scientist Dr Debojyoti Chakraborty, who has developed Feluda along with Dr Souvik Maiti, spoke to Sanchita Sharma about test strip.
Low-cost ‘Feluda’ test to detect virus in an hour likely in 4 weeks
06:42pm, Tuesday, 12'th May 2020
Called Feluda, the test is named after a fictional detective created by the late Satyajit Ray, although it is also an acronym for FNCAS9 Editor-Linked Uniform Detection Assay.
10 Disruptive Tech Stocks to Invest In
04:35pm, Tuesday, 12'th May 2020
We're a small team of writers and researchers here at Nanalyze, so we often leverage the efforts of others and take credit for it like they taught us to do in business school. We recently spoke with o
Intellia Therapeutics, Inc. (NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, is presenting three oral pre
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
11:43am, Monday, 11'th May 2020
The analysts might have been a bit too bullish on Intellia Therapeutics, Inc. (NASDAQ:NTLA), given that the company...
Caribou Biosciences Appoints Cherry Thomas, MD as Senior Vice President of Clinical Development
12:00am, Monday, 11'th May 2020
Caribou Biosciences, Inc., a leading CRISPR genome editing company, today announced the appointment of Cherry Thomas, MD, as Senior Vice President of
Intellia Therapeutics, Inc. (NTLA) Q1 2020 Earnings Call Transcript
05:31pm, Saturday, 09'th May 2020
Joining me on today's call from Intellia are Dr. John Leonard, our Chief Executive Officer; Dr. Laura Sepp-Lorenzino, our Chief Scientific Officer; and Glenn Goddard, our Chief Financial Officer. Fol
Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q1 2020 Results - Earnings Call Transcript
02:30am, Friday, 08'th May 2020
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2020 Earnings Conference Call May 07, 2020 8:00 AM ET Company Participants Lina Li - Associate Director of Investor
Intellia Therapeutics Inc (NTLA) Reports Q1 Loss, Misses Revenue Estimates
01:15pm, Thursday, 07'th May 2020
Intellia Therapeutics Inc (NTLA) delivered earnings and revenue surprises of -61.54% and -46.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the s
Recap: Intellia Therapeutics Q1 Earnings
12:38pm, Thursday, 07'th May 2020
Shares of Intellia Therapeutics (NASDAQ:NTLA) were flat in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were down 28.57% over the past year to ($0.63),
Intellia Therapeutics Announces First Quarter 2020 Financial Results
11:30am, Thursday, 07'th May 2020
Intellia Therapeutics, Inc. (NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, today reported operational highl
